Microbix Biosystems Statistics

Total Valuation

MBXBF has a market cap or net worth of 61.80 million. The enterprise value is 55.08 million.

Market Cap	61.80M
Enterprise Value	55.08M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	281.59M
Shares Outstanding	n/a
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	+3.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	118.39M

Valuation Ratios

The trailing PE ratio is 56.77.

PE Ratio	56.77
Forward PE	n/a
PS Ratio	3.91
PB Ratio	2.86
P/TBV Ratio	3.28
P/FCF Ratio	35.26
P/OCF Ratio	22.61
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.03, with an EV/FCF ratio of 31.43.

EV / Earnings	50.60
EV / Sales	3.31
EV / EBITDA	22.03
EV / EBIT	37.18
EV / FCF	31.43

Financial Position

The company has a current ratio of 9.36, with a Debt / Equity ratio of 0.17.

Current Ratio	9.36
Quick Ratio	6.15
Debt / Equity	0.17
Debt / EBITDA	1.57
Debt / FCF	2.12
Interest Coverage	2.15

Financial Efficiency

Return on equity (ROE) is 5.32% and return on invested capital (ROIC) is 3.57%.

Return on Equity (ROE)	5.32%
Return on Assets (ROA)	3.27%
Return on Invested Capital (ROIC)	3.57%
Return on Capital Employed (ROCE)	5.53%
Revenue Per Employee	158,084
Profits Per Employee	10,886
Employee Count	100
Asset Turnover	0.59
Inventory Turnover	1.33

Taxes

In the past 12 months, MBXBF has paid 104,750 in taxes.

Income Tax	104,750
Effective Tax Rate	8.78%

Stock Price Statistics

The stock price has decreased by -10.83% in the last 52 weeks. The beta is 0.27, so MBXBF's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-10.83%
50-Day Moving Average	0.26
200-Day Moving Average	0.27
Relative Strength Index (RSI)	31.84
Average Volume (20 Days)	7,695

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MBXBF had revenue of 15.81 million and earned 1.09 million in profits. Earnings per share was 0.01.

Revenue	15.81M
Gross Profit	9.13M
Operating Income	1.41M
Pretax Income	1.19M
Net Income	1.09M
EBITDA	2.26M
EBIT	1.41M
Earnings Per Share (EPS)	0.01

Full Income Statement

Balance Sheet

The company has 10.11 million in cash and 3.72 million in debt, giving a net cash position of 6.39 million.

Cash & Cash Equivalents	10.11M
Total Debt	3.72M
Net Cash	6.39M
Net Cash Per Share	n/a
Equity (Book Value)	21.61M
Book Value Per Share	0.15
Working Capital	16.12M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.73 million and capital expenditures -980,890, giving a free cash flow of 1.75 million.

Operating Cash Flow	2.73M
Capital Expenditures	-980,890
Free Cash Flow	1.75M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 57.74%, with operating and profit margins of 8.91% and 6.89%.

Gross Margin	57.74%
Operating Margin	8.91%
Pretax Margin	7.55%
Profit Margin	6.89%
EBITDA Margin	14.27%
EBIT Margin	8.91%
FCF Margin	11.09%

Dividends & Yields

MBXBF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.56%
Shareholder Yield	n/a
Earnings Yield	1.76%
FCF Yield	2.84%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MBXBF has an Altman Z-Score of 3.89 and a Piotroski F-Score of 7.

Altman Z-Score	3.89
Piotroski F-Score	7